Skip to content

Why the process of selecting a pharma peer reviewer needs an AI upgrade

Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.

Why the process of selecting a pharma peer reviewer needs an AI upgrade
Published: | 4 min read

Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.

DeSci Labs

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information